Current role
Mittie Doyle, M.D., FACR
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mittie Doyle, M.D., FACR
Avalo Therapeutics, Inc. reported in an 8-K filed July 16, 2024 that Mittie Doyle, M.D., FACR was appointed Chief Medical Officer, effective July 15, 2024.
“On July 16, 2024, Avalo Therapeutics, Inc. (the “Company”) announced the appointment of Mittie Doyle, M.D., FACR, as Chief Medical Officer, effective July 15, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Avalo Therapeutics, Inc. (AVTX)
SEC 8-K
Current2024-07-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Avalo Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Garry A. Neil CEO
- Garry Neil CEO, Board Member
- Michael Cola CEO, Chairman, Board Member
- Michael F. Cola CEO, Board Member
- Peter Greenleaf CEO
- Michael Heffernan Chairman, Board Member
- Sol Barer Chairman, Board Member
- Sol J. Barer Chairman, Board Member
- Chris Sullivan CFO
- Christopher Sullivan CFO, Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.